United States · FDA National Drug Code directory

Migraine Relief

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 81522-205_f212f808-9330-2b65-e053-2995a90a5775
Product NDC: 81522-205
Form: TABLET
Composition / generic term: ACETAMINOPHEN, ASPIRIN and CAFFEINE
Labeler: FSA STORE INC.
Marketing category: ANDA
Marketing start / end (source format): 20230111
Source listing expiry: 20261231

Source-listed ingredients

ACETAMINOPHEN — 250 mg/1
ASPIRIN — 250 mg/1
CAFFEINE — 65 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

1 BOTTLE, PLASTIC in 1 CARTON (81522-205-03) / 100 TABLET in 1 BOTTLE, PLASTIC · 81522-205-03

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →